TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
The presence of diffuse anaplasia in Wilms tumours (DAWT) is associated with TP53 mutations and poor outcome. As patients receive intensified treatment, we sought to identify whether TP53 mutational status confers additional prognostic information.We studied 40 patients with DAWT with anaplasia in t...
Main Authors: | Mariana Maschietto, Richard D Williams, Tasnim Chagtai, Sergey D Popov, Neil J Sebire, Gordan Vujanic, Elizabeth Perlman, James R Anderson, Paul Grundy, Jeffrey S Dome, Kathy Pritchard-Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4196953?pdf=render |
Similar Items
-
Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors
by: Taryn D. Treger, et al.
Published: (2018-12-01) -
A molecular genetic analysis of Wilms tumour and Wilms tumour predisposition syndromes
by: Grundy, Richard Guy
Published: (1997) -
Clinical significance of anaplasia in childhood rhabdomyosarcoma
by: Iman Sidhom, et al.
Published: (2015-06-01) -
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
by: George D. Cresswell, et al.
Published: (2016-07-01) -
Osteossarcomas humanos de alto grau: imunoexpressão de p53, erb-2 e P-glicoproteína, e correlação com o parâmetro anaplasia P-glycoprotein, erb2 and p53 expression in high-grade human osteosarcomas and their correlation with anaplasia
by: Maria Teresa de Seixas Alves, et al.
Published: (2008-04-01)